Systemic Antihypertensive Medication and Incident Open-angle Glaucoma

Ophthalmology

Volumn 114, Issue 12, 2007, Pages 2221-2226

  Müskens, Rogier P H M ^a,b   de Voogd, Simone ^b   Wolfs, Roger C W ^b   Witteman, Jacqueline C M ^b   Hofman, Albert ^b   de Jong, Paulus T V M ^b,c,d   Stricker, Bruno H C ^b   Jansonius, Nomdo M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; RISK REDUCTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIURETICS; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 36549027877     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.03.047     Document Type: Article

References (45)

1. Le A., Mukesh B.N., McCarty C.A., and Taylor H.R. Risk factors associated with the incidence of open-angle glaucoma: the Visual Impairment Project. Invest Ophthalmol Vis Sci 44 (2003) 3783-3789
2. Heijl A., Leske M.C., Bengtsson B., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
3. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30
4. Wolfs R.C., Klaver C.C., Ramrattan R.S., et al. Genetic risk of primary open-angle glaucoma: population-based familial aggregation study. Arch Ophthalmol 116 (1998) 1640-1645
5. Tielsch J.M., Katz J., Sommer A., et al. Family history and risk of primary open angle glaucoma: the Baltimore Eye Survey. Arch Ophthalmol 112 (1994) 69-73
6. Rosenthal A.R., and Perkins E.S. Family studies in glaucoma. Br J Ophthalmol 69 (1985) 664-667
7. Leske M.C., Nemesure B., He Q., et al. Patterns of open-angle glaucoma in the Barbados Family Study. Ophthalmology 108 (2001) 1015-1022
8. de Voogd S., Ikram M.K., Wolfs R.C., et al. Incidence of open-angle glaucoma in a general elderly population. The Rotterdam Study. Ophthalmology 112 (2005) 1487-1493
9. Ramrattan R.S., Wolfs R.C., Panda-Jonas J.B., et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol 119 (2001) 1788-1794
10. Mitchell P., Hourihan F., Sandbach J., and Wang J.J. The relationship between glaucoma and myopia. The Blue Mountains Eye Study. Ophthalmology 106 (1999) 2010-2015
11. Wong T.Y., Klein B.E., Klein R., et al. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 110 (2003) 211-217
12. Grodum K., Heijl A., and Bengtsson B. Refractive error and glaucoma. Acta Ophthalmol Scand 79 (2001) 560-566
13. Dielemans I., Vingerling J.R., Algra D., et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: the Rotterdam Study. Ophthalmology 102 (1995) 54-60
14. Bonomi L., Marchini G., Marraffa M., et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 107 (2000) 1287-1293
15. Tielsch J.M., Katz J., Sommer A., et al. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol 113 (1995) 216-221
16. Hulsman CA, Borger PH, Vingerling JR, et al. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam Study. Arch Ophthalmol. In press.
17. Yu D.Y., Su E.N., Cringle S.J., et al. Systemic and ocular vascular roles of the antiglaucoma agents b-adrenergic antagonists and Ca2+ entry blockers. Surv Ophthalmol 43 suppl (1999) s214-s222
18. Takayama J., Tomidokoro A., Tamaki Y., and Araie M. Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure. Invest Ophthalmol Vis Sci 46 (2005) 1409-1419
19. Flammer J., Pache M., and Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 20 (2001) 319-349
20. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7 (1991) 403-422
21. Wolfs R.C., Borger P.H., Ramrattan R.S., et al. Changing views on open-angle glaucoma: definitions and prevalences-the Rotterdam Study. Invest Ophthalmol Vis Sci 41 (2000) 3309-3321
22. Ikram M.K., Witteman J.C., Vingerling J.R., et al. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension 47 (2006) 189-194
23. Heeringa J., van der Kuip D.A., Hofman A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27 (2006) 949-953
24. Bleumink G.S., Knetsch A., Sturkenboom M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 25 (2004) 1614-1619
25. de Torbal A., Boersma E., Kors J.A., et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 27 (2006) 729-736
26. Hollander M., Bots M.L., del Sol A.I., et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 105 (2002) 2872-2877
27. Maitland-van der Zee A.H., Klungel O.H., Stricker B.C., et al. Repeated nitrate prescriptions as a potential marker for angina pectoris: a comparison with medical information from the Rotterdam Study. Pharm World Sci 25 (2003) 70-72
28. de Voogd S., Ikram M.K., Wolfs R.C., et al. Is diabetes mellitus a risk factor for open-angle glaucoma?. The Rotterdam Study. Ophthalmology 113 (2006) 1827-1831
29. Langman M.J., Lancaster R.J., Cheng K.K., and Stewart P.M. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol 89 (2005) 960-963
30. Klein B.E., Klein R., and Knudtson M.D. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 89 (2005) 284-287
31. Orgul S., Gugleta K., and Flammer J. Physiology of perfusion as it relates to the optic nerve head. Surv Ophthalmol 43 suppl (1999) s17-s26
32. Kitazawa Y., Shirai H., and Go F.J. The effect of Ca2(+)-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 227 (1989) 408-412
33. Netland P.A., Chatuverdi N., and Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 115 (1993) 608-613
34. Tamaki Y., Araie M., Tomita K., and Tomidokoro A. Time-course of changes in nicardipine effects on microcirculation in retina and optic nerve head in living rabbit eyes. Jpn J Ophthalmol 40 (1996) 202-211
35. Messmer C., Flammer J., and Stumpfig D. Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am J Ophthalmol 112 (1991) 678-681
36. Kaiser H.J., Flammer J., Stumpfig D., and Hendrickson P. Longterm visual field follow-up of glaucoma patients treated with beta-blockers. Surv Ophthalmol 38 suppl (1994) S156-S159
37. Hoste A.M. In vitro studies of the effects of beta-adrenergic drugs on retinal and posterior ciliary microarteries. Surv Ophthalmol 43 suppl (1999) S183-S190
38. Mitchell P., Smith W., Chey T., and Healey P.R. Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology 104 (1997) 712-718
39. Klein B.E., Klein R., and Jensen S.C. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology 101 (1994) 1173-1177
40. Mitchell P., Lee A.J., Rochtchina E., and Wang J.J. Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma 13 (2004) 319-326
41. Dielemans I., de Jong P.T., Stolk R., et al. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population: the Rotterdam Study. Ophthalmology 103 (1996) 1271-1275
42. Leske M.C., Wu S.Y., Nemesure B., and Hennis A. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 120 (2002) 954-959
43. Tielsch J.M., Katz J., Quigley H.A., et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 102 (1995) 48-53
44. Leske M.C., Connell A.M., Wu S.Y., et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. Arch Ophthalmol 119 (2001) 89-95
45. Mukesh B.N., McCarty C.A., Rait J.L., and Taylor H.R. Five-year incidence of open-angle glaucoma: the Visual Impairment Project. Ophthalmology 109 (2002) 1047-1051